3802|10000|Public
25|$|Blood {{tests for}} lactate are {{performed}} {{to determine the}} status of the acid base homeostasis in the body. <b>Blood</b> <b>sampling</b> for this purpose is often by arterial <b>blood</b> <b>sampling</b> (even if it is more difficult than venipuncture), because lactate differs substantially between arterial and venous levels, and the arterial level is more representative for this purpose.|$|E
25|$|These {{confidence}} intervals reflect random error, {{but do not}} compensate for systematic error, {{which in this case}} can arise from, for example, the reference group not having fasted long enough before <b>blood</b> <b>sampling.</b>|$|E
25|$|Foetal haematocrit for the {{assessment}} of foetal anemia, Rh isoimmunization, or hydrops can be determined by percutaneous umbilical <b>blood</b> <b>sampling</b> (PUBS), which is done by placing a needle through the abdomen into the uterus and taking a portion of the umbilical cord.|$|E
40|$|Aim To {{investigate}} whether incorrect order of draw of <b>blood</b> <b>samples</b> during phlebotomy causes in vitro potassium ethylenediaminetetraacetic acid EDTA (kEDTA) contamination of <b>blood</b> <b>samples.</b> Methods Serum kEDTA, potassium, calcium, magnesium, alkaline phosphatase, zinc and iron concentrations were measured in <b>blood</b> <b>samples</b> drawn {{before and after}} collecting blood into kEDTA containing sample tubes by an experienced phlebotomist using the Sarstedt Safety Monovette system. Results EDTA was undetectable in all samples. The concentrations of other analytes were similar in <b>blood</b> <b>samples</b> drawn before and after collection of the EDTA <b>blood</b> <b>sample.</b> Conclusion Order of draw of <b>blood</b> <b>samples</b> using the Sarstedt Safety Monovette system {{has no effect on}} serum biochemistry results, when samples are taken by an experienced phlebotomist...|$|R
40|$|This paper {{reports a}} study of the {{dielectric}} properties of pregnant women’s <b>blood</b> <b>samples</b> as well non-pregnant women’s <b>blood</b> <b>samples</b> at microwave frequencies. The cavity perturbation technique in the frequency range between 2 and 3 GHz was used in this study. It is observed that the dielectric constant of pregnant women’s <b>blood</b> <b>samples</b> is higher than that of non-pregnant women’s <b>blood</b> <b>samples,</b> and the conductivity of pregnant women’s <b>blood</b> <b>samples</b> is higher than that of non-pregnant women’s <b>blood</b> <b>samples.</b> This is a novel in-vitro method of determining pregnancy. The same samples were also subjected to investigations in the clinical laboratory for quantitative pregnancy blood tests. Determination of pregnancy will help the woman to make preparations for proper prenatal care or family planning...|$|R
40|$|Maternal-fetal {{exchange}} of a potent tobacco-related human carcinogen, 4 -aminobiphenyl, was studied in smoking (n= 14) and nonsmoking (n= 38) pregnant women. /V-Hydroxy- 4 -aminobiphenyl, the active metabolite of 4 -aminobiphenyl, forms chemical addition products (adducts) with hemoglobin. Levels of 4 -aminobiphenyl hemoglobin adducts were measured in maternal-fetal paired <b>blood</b> <b>samples</b> obtained from smoking and nonsmoking women during labor and delivery. Carcinogen-hemoglobin adducts were detected in all maternal and fetal <b>blood</b> <b>samples.</b> Levels of such adducts {{were significantly higher}} (f <. 001) in maternal and fetal <b>blood</b> <b>samples</b> from smokers: the mean 4 -aminobiphenyl hemoglobin adduct level was 92 ± 54 pg/g of hemoglobin in <b>blood</b> <b>samples</b> from fetuses of smokers, and 17 ± 13 pg/g of hemoglobin in <b>blood</b> <b>samples</b> fro...|$|R
25|$|From 24 to 34 {{weeks of}} gestation, when the fetus is {{typically}} viable, blood {{can be taken}} from the cord {{in order to test}} for abnormalities (particularly for hereditary conditions). This diagnostic genetic test procedure is known as percutaneous umbilical cord <b>blood</b> <b>sampling.</b>|$|E
25|$|Prenatal {{and other}} {{diagnostic}} techniques such as immunocytochemistry (ICC) evaluation are usually followed by FISH or Polymerase Chain Reaction to detect chromosomal aneuploidies. Maternal <b>blood</b> <b>sampling</b> for fetal cells, often used to identify risk of trisomies 18 or 21, poses less risk as compared to amniocentesis and chorionic villous sampling (CVS). Chorionic villus sampling utilizes placental tissue to give information about fetal chromosome status and has been used since the 1970s. In addition to CVS, amniocentesis {{can be used to}} obtain fetal karyotype by examining fetal cells in amniotic fluid. It was first performed in 1952 and became standard practice in the 1970s. The odds of having a child with polysomy increases as the age of the mother increases, so pregnant women over the age of 35 are tested.|$|E
25|$|Prenatal diagnosis: Used {{to detect}} {{changes in a}} fetus's genes or {{chromosomes}} before birth. This type of testing is offered to couples with {{an increased risk of}} having a baby with a genetic or chromosomal disorder. In some cases, prenatal testing can lessen a couple's uncertainty or help them decide whether to abort the pregnancy. It cannot identify all possible inherited disorders and birth defects, however. One method of performing a prenatal genetic test involves an amniocentesis, which removes a sample of fluid from the mother’s amniotic sac 15 to 20 or more weeks into pregnancy. The fluid is then tested for chromosomal abnormalities such as Down syndrome (Trisomy 21) and Trisomy 18, which can result in neonatal or fetal death. Test results can be retrieved within 7–14 days after the test is done. This method is 99.4% accurate at detecting and diagnosing fetal chromosome abnormalities. Although there is a risk of miscarriage associated with an amniocentesis, the miscarriage rate is only 1/400. Another method of prenatal testing is Chorionic Villus Sampling (CVS). Chorionic villi are projections from the placenta that carry the same genetic makeup as the baby. During this method of prenatal testing, a sample of chorionic villi is removed from the placenta to be tested. This test is performed 10–13 weeks into pregnancy and results are ready 7–14 days after the test was done. Another test using blood taken from the fetal umbilical cord is percutaneous umbilical cord <b>blood</b> <b>sampling.</b>|$|E
2500|$|On 20 November, {{the local}} Red Cross in Kankan Prefecture sent [...] <b>blood</b> <b>samples</b> via a courier when the taxi he was {{traveling}} in was stopped by robbers. The bandits made off with the cooler bag containing the <b>blood</b> <b>samples.</b> The Guinea authorities made a public appeal {{for the return of}} the <b>blood</b> <b>samples.</b> The robbery occurred near the town of Kissidougou.|$|R
40|$|In {{air freight}} industry, <b>blood</b> <b>samples</b> are {{classified}} as time and temperature sensitive biologically produced pharmaceuticals. To determine the level of influence that the handling processes and air transportation have on <b>blood</b> <b>sample</b> quality, a {{research has been conducted}} through transportation of whole <b>blood</b> <b>samples</b> on two European scheduled routes. Two shipping models were defined: the standard one without defined transportation temperature regime and the controlled one, where transportation is conducted under appropriate temperature regime. The <b>blood</b> <b>samples</b> were packed and transported respecting all relevant national and international regulations. The analysis was conducted and the results compared to control sample kept in the laboratory. Significant changes were identified on all components analyzed after crosschecking with the control sample. KEY WORDS: regulatory issues, <b>blood</b> <b>sample</b> quality, shipping model, packaging instruction, temperature profile...|$|R
40|$|The {{investigators}} role {{of drugs}} unit in <b>blood</b> <b>sample</b> analysis of evidence criminal narcotics and psychotropic, {{the process of}} examination of <b>blood</b> <b>samples</b> based on the Healthy Minister Decision No. 923 IMenkes/SK/X/ 12009 on Technical Guidelines for Laboratory Investigation Narcotic Drugs and Psychotropic. The implementation of role, founded obstacle is: constraints on evidentiary analysis of <b>blood</b> <b>samples</b> in case of narcotic and psychotropic crime, among others: investigators were given 4 days, investigators here have difficulties because the examination of <b>blood</b> <b>samples</b> must be made at firensic laboratory in Jakarta, which {{takes a long time}} especially if conditions are unfavorable, limited personnel from Lampung Regional Police Drug Unit; legal culture of society, people seem less concerned with the abuse of narcotics. The power forensic results of <b>blood</b> <b>samples</b> as mail proof tool...|$|R
500|$|Early {{scientific}} bird collections included those {{belonging to}} Pallas and Naumann in Germany, Latham and Tunstall in England and Adanson in France. Collections grew in size with increasing maritime activity, exploration and colonialism. For example, Charles Darwin collected over 400 bird specimens during his travels on the Beagle, {{and it was}} many years after his return to England that his bird collections from the Galapagos inspired (in part) his theory of evolution through natural selection. The Paris museum had 463 bird specimens in 1793 and this grew to 3411 in 1809; The Berlin museum had 2000 specimens in 1813 growing to 13,760 around 1850. In 1753 there were 1172 bird specimens in the museum established by Sir Hans Sloane but these appear to have perished before they moved to the British Museum. Early specimens from Captain Cook's voyages {{as well as those}} described by Latham in his General Synopsis of Birds (1781–1785) were also lost possibly due to poor preservation technique. The scale of collections grew {{to the point where they}} needed more space and full-time curators. In the earliest days of ornithology, collecting was the dominant method of bird observation and study. This approach has diminished with the growth of the discipline. The use of mist-netting and photography, <b>blood</b> <b>sampling</b> (for DNA, immunological and other studies), the development of optics and the use of other new techniques for studying birds have reduced the need to collect specimens for research, yet collections continue to act as a vital shared resource for science (particularly taxonomy) and conservation. [...] In an era of mass extinction, bird collections will evidence lost species.|$|E
2500|$|In conjunction, {{measuring}} {{blood glucose}} level every 10 to 15 minutes after ingestion will show a [...] "flat curve" [...] in individuals with lactose malabsorption, while the lactase persistent will have a significant [...] "top", with a typical [...] elevation of 50% to 100%, within one to two hours. However, due {{to the need for}} frequent <b>blood</b> <b>sampling,</b> this approach has been largely replaced by breath testing.|$|E
5000|$|Issue 2 - Automated Inpatient <b>Blood</b> <b>Sampling</b> for Glucose Measurement ...|$|E
30|$|Total RNA {{yield and}} quality were {{assessed}} for stabilized whole <b>blood</b> <b>samples</b> and for isolated cell populations. Cell separation from K 2 -EDTA anticoagulated whole <b>blood</b> <b>samples</b> started within 30 minutes after venipuncture.|$|R
30|$|After 70 [*]days of salt loaded {{diets and}} prior to {{administration}} of the extracts, <b>blood</b> <b>samples</b> were collected from the rabbits using sterilized hypodermic needles. At day 78 after treatment with the extracts {{for a period of}} 7 [*]days, <b>blood</b> <b>samples</b> were also collected from the animals. The <b>blood</b> <b>samples</b> were centrifuged at 3500 [*]rpm for 10 [*]min to obtain a clear serum which was used for biochemical analysis.|$|R
50|$|An AMA member sent a <b>blood</b> <b>sample</b> to an Abrams practitioner, and {{got back}} a {{diagnosis}} that the patient had malaria, diabetes, cancer and syphilis. The <b>blood</b> <b>sample</b> was in fact from a Plymouth Rock rooster.|$|R
5000|$|... #Caption: This image shows {{anterior}} <b>blood</b> <b>sampling</b> {{from the}} umbilical cord.|$|E
50|$|Blood {{tests for}} lactate are {{performed}} {{to determine the}} status of the acid base homeostasis in the body. <b>Blood</b> <b>sampling</b> for this purpose is often by arterial <b>blood</b> <b>sampling</b> (even if it is more difficult than venipuncture), because lactate differs substantially between arterial and venous levels, and the arterial level is more representative for this purpose.|$|E
5000|$|Anemia of {{prematurity}} from frequent <b>blood</b> <b>sampling</b> for laboratory testing, {{combined with}} insufficient RBC production ...|$|E
40|$|The {{dependence}} on hematocrit of whole blood viscoelasticity {{must be considered}} in order to compare pathological <b>blood</b> <b>samples</b> to normal ones. If one wants to calculate the measured values to a standard hematocrit value, the hematocrit dependence for the pathological sample must be available. As the latter however is unknown, the same dependence is assumed for both normal and pathological <b>blood</b> <b>samples.</b> To prove the validity of this assumption, hematocrit dependence of random <b>blood</b> <b>samples</b> from different diseases (cerebral and coronary vascular and myocardial disorders) were investigated. A statistical analysis showed the assumption as invalid. Therefore, it will be recommended to evaluate pathological <b>blood</b> <b>samples</b> at the measured hematocrit...|$|R
40|$|The {{presence}} of Ehrlichia canis DNA in <b>blood</b> <b>samples</b> from 47 Aruban domestic dogs, exhibiting signs of canine monocytic ehrlichiosis (CME), was tested. PCR amplification and Reverse line blot hybridization techniques {{were used in}} order to test for the {{presence of}} E. canis DNA in the <b>blood</b> <b>samples.</b> Ehrlichia canis DNA was only detected in one (2. 1 %) of the 47 <b>blood</b> <b>samples.</b> Serological testing for Ehrlichia canis antibodies using the Snap® 3 Dx ® test was also performed on the 47 <b>blood</b> <b>samples.</b> Out of those 47 <b>blood</b> <b>samples</b> 22 (46. 8 %) were positive for E. canis antibodies. In order to test the effectivityof the treatment of CME, <b>blood</b> <b>samples</b> were taken at 30 days and 60 days post treatment. The PCR amplification, Reverse line blot hybridization (RLB) and serological testing methods were repeated for these <b>blood</b> <b>samples</b> as well. None of these <b>blood</b> <b>samples</b> were positive for E. canis DNA, but 38 % of the <b>blood</b> <b>samples</b> which were previously negative on the Snap® 3 Dx ® test were now positive. This finding suggests that the methods used for demonstrating E. canis DNA in this research were insensitive. The <b>blood</b> <b>samples</b> were also tested for other tick borne pathogens using the PCR and RLB methods. Respectively Babesia canis vogeli DNA was present in 6 (12. 8 %) and Anaplasma phagocytophilum DNA was present in 1 (2. 1 %) of the 47 pretreatment <b>blood</b> <b>samples.</b> This {{is the first time that}} Babesia canis vogeli infections have been identified in the Aruban dog population, more research will be needed in order to determine the clinical significance of this infection. A. phagocytophilum is a zoonotic disease spread by ticks of the Ixodus species, until now only Rhipicephalus sanguineus ticks have been identified among the Aruban dog population. The positive A. phagocytophilum result could have been due to a cross reaction with A. platys on the RLB. More research is needed on the tick species present in the Aruban dog population in order to determine the relevance of A. phagocytophilum infections in dogs as well as its zoonotic risk...|$|R
5000|$|Performing {{southern}} blots with primate <b>blood</b> <b>samples</b> and gag, pol and pro probes (from 100MSRV) suggested HERV-W {{entered the}} genome of catarrhines over 23 million years ago. [...] Later, <b>blood</b> <b>samples</b> from various primates: hominoids, Old World monkeys, New World monkeys and prosimians were probed using a fluorescently labeled HERV-W element {{derived from the}} gorilla fosmid library. Fluorescence in situ hybridization (FISH) revealed HERV-W elements in all the primate <b>blood</b> <b>samples</b> except the tupaia.|$|R
5000|$|<b>Blood</b> <b>sampling</b> {{for blood}} cultures, {{performed}} similarly as that for {{tests on the}} fluid itself above ...|$|E
5000|$|Arterial <b>blood</b> <b>sampling,</b> such as by {{radial artery}} puncture. This {{can be done}} for {{arterial}} blood gas analysis.|$|E
5000|$|Owen Mumford Ltd of Woodstock, Oxfordshire for Unistik 3 safety lancets for <b>blood</b> <b>sampling</b> in {{hospitals}} and by patients at home.|$|E
30|$|From {{each study}} participant, a <b>blood</b> <b>sample</b> was {{collected}} {{immediately prior to}} vaccination. <b>Blood</b> <b>samples</b> were also collected 3 - and 28 -days post-vaccination. Serum and DNA were isolated from these samples, using standard protocols and QiaGen columns.|$|R
40|$|Canadian {{health care}} {{professionals}} and lawyers serving on ethics committees were questioned about their views on pharmacokinetic research in newborn infants who {{are not likely to}} benefit directly from the results. Of the 50 respondents 13 felt that <b>blood</b> <b>samples</b> should be taken only for therapeutic reasons; 10 of the 13 argued that additional <b>blood</b> <b>samples</b> should not be taken, because there is no direct benefit to the infant; and 8 felt that proxy consent cannot be given for invasive nontherapeutic research. Four of the five participating lawyers would not permit additional <b>blood</b> <b>samples</b> to be taken. Of the 37 respondents who would permit additional <b>blood</b> <b>samples</b> to be taken, 27 felt that the number of samples taken should depend on the researcher's justification for that number of samples; only 7 of the respondents had a clear idea of what the "upper limit" of the number of <b>blood</b> <b>samples</b> should be...|$|R
30|$|Sixteen {{clinical}} samples (13 Widal positive sera and 3 {{blood culture}} positive <b>blood</b> <b>samples)</b> {{were collected from}} various hospitals in the city. 4 <b>blood</b> <b>samples</b> collected from apparently healthy individuals were spiked with different concentrations of serovar Typhi cells.|$|R
5000|$|Training {{animals to}} voluntarily co-operate with {{procedures}} (e.g. <b>blood</b> <b>sampling)</b> {{so that they}} have greater control over the procedure reduce distress ...|$|E
5000|$|Capillary <b>blood</b> <b>sampling</b> {{can be used}} to test for, for example, {{blood glucose}} (such as in blood glucose monitoring), hemoglobin, pH and lactate ...|$|E
5000|$|... #Caption: Critical Care: The SafeSet Closed <b>Blood</b> <b>Sampling</b> System from ICU Medical helps clinicians {{conserve}} {{blood in}} the operating room and intensive care unit.|$|E
40|$|Background: The {{national}} average for laboratory rejection of <b>blood</b> <b>samples</b> ranges from 0. 3 % to 0. 8 %. The rate of rejection {{at a local}} emergency department averaged 2. 8 % in 2014. Purpose: Discover prevalent causes of laboratory <b>blood</b> <b>sample</b> rejection in the emergency department and determine best practice for maintaining acceptable rejection rates. Methods: Analyze data from the hospital laboratory to identify reasons for <b>blood</b> <b>sample</b> rejection and which personnel procured the rejected samples. Review literature to find common sources of error and explore evidence based practices in drawing blood for laboratory testing. Results: Data showed that hemolysis and clotting were {{the main reasons for}} <b>blood</b> <b>sample</b> rejection. Registered nurses were responsible for the largest number of rejections. Literature states best practice is to avoid using intravenous catheter starts for drawing <b>blood</b> <b>samples</b> and to use phlebotomists for lab draws rather than registered nurses. Discussion/Recommendations: Registered nurses may have higher rejection rates because of their tendency to draw blood from intravenous catheter starts. Therefore, the first recommendation is to revise policy and educate personnel to avoid this method of obtaining <b>blood</b> <b>samples.</b> The second recommendation is to use a dedicated phlebotomist or technician for blood draws instead of registered nurses. Considering the effect of laboratory rejections on efficient care delivery, healthcare costs, and patient satisfaction, reducing the <b>blood</b> <b>sample</b> rejection rate in the emergency department should be prioritized...|$|R
30|$|Results: In the {{pre-intervention}} period 2905 <b>blood</b> <b>samples</b> were analyzed, 448 (15.4  %) positive blood cultures from 206 {{patients were}} obtained; in the interventional period 2742 <b>blood</b> <b>samples</b> were analyzed, 470 (17.1  %) positive blood cultures from 230 patients were obtained.|$|R
30|$|The family {{physician}} {{of the athlete}} took a first <b>blood</b> <b>sample</b> 11  days before the event. During the event, <b>blood</b> <b>samples</b> were taken on Day 7, Day 13, Day 16, Day 19, Day 24 and Day 29. After the event, <b>blood</b> <b>samples</b> were drawn 7  days and 78  days after the finish. All samples were drawn after the stages at home of the athlete and analysed in the laboratory of Hôpital du Sacré-Coeur de Montréal, Québec, Canada.|$|R
